Experience

Reliance Life Sciences has designed, planned and conducted clinical research in all phases of product development.

If there is a specific type of study, therapeutic indication or special patient population that you are interested in that is not listed below, please email at ClinicalResearch.Enquiry@relbio.com for more information.

Pre-clinical Experience:

• Acute study
• Repeated dose toxicity study
• Skin irritation
• Skin sensitization
• Genotoxicity studies
• Ames
• Micronucleus test (in vitro and in vivo)
• Chromosomal aberration (in vitro)
• Cytotoxicity assay
• Genetic and microbial monitoring of laboratory animals

Phase I & BA/BE Experience:

• Pilot studies
• Pivotal Studies
• Two-stage design studies
• Steady State studies
• Drug-drug interaction studies
• Food-drug interaction studies
• Special population studies
• Patient BE studies
• Pharmacokinetic & Pharmacodynamic studies in biosimilars
• Human mass balance studies
• Cardiac safety studies (TQTc)
• Skin blanching studies
• Proof of Concept studies
• Single Ascending Dose (SAD) studies
• Multiple Ascending Dose (MAD) studies

Phase II – IV Therapeutic Experience:

• Acute Medical Illness
• Cardiovascular
• Central Nervous System
• Circulatory System
• Dermatology
• Endocrinology
• Gastroenterology
• Gynecology
• Hematology
• Immune System
• Infectious Diseases
• Medical Devices
• Musculoskeletal
• Nephrology
• Oncology
• Ophthalmology
• Orthopedic
• Psychiatry
• Respiratory
• Surgery